Ciprofloxacine Aurobindo

Medicinal product

(Invented) name

Ciprofloxacine Aurobindo

Active substance (s)

Ciprofloksacinas

Strength

500 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01MA02, Ciprofloxacin

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2021-11-29

Date of renewal

Documents

1628_Ciprofloxacine Aurobindo_2021-11-29.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Ciprofloksacinas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107604	93709	1093709	lizdinė plokštelė	N20		Receptinis	LT/L/21/1628/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-11-29	Registruotas